![Marion McCourt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 9 M $ in data 31/05/2026
Marion McCourt currently works at Girls On The Run International, as Director and Regeneron Pharmaceuticals, Inc., as Executive Vice President-Commercial from 2021.
Ms. McCourt also formerly worked at AstraZeneca Canada, Inc., as President & Chief Executive Officer from 2011 to 2012, SCYNEXIS, Inc., as Independent Director from 2017 to 2018, CytomX Therapeutics, Inc., as Independent Director from 2017 to 2018, Amgen, Inc., as Vice President-US Commercial Operations from 2013 to 2016, AstraZeneca PLC, as Chief Operating Officer-United States Region from 2011 to 2013, AstraZeneca Pharmaceuticals LP, as Vice President-Managed Markets & Government, Medivation LLC (California), as Chief Operating Officer in 2016, and Sio Gene Therapies, Inc., as President & Chief Operating Officer from 2017 to 2018.
Ms. McCourt received her undergraduate degree from Lafayette College.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 09/12/2025 | 14.546 ( 0,01% ) | 9 M $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Corporate Officer/Principal | 12/02/2018 |
Girls On The Run International
 Girls On The Run International Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes girl empowerment by teaching life skills through lessons and running | Direttore/Membro del Consiglio | - |
| Società | Posizione | Fine |
|---|---|---|
| SCYNEXIS, INC. | Direttore/Membro del Consiglio | 18/09/2018 |
| CYTOMX THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 13/06/2018 |
| SIO GENE THERAPIES INC. | Presidente | 12/02/2018 |
| MEDIVATION INC | Direttore operativo | 01/09/2016 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 11 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Regeneron Pharmaceuticals, Inc.
 Regeneron Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops, manufactures and commercializes medicines for diseases | Health Technology |
AstraZeneca PLC
 AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
SCYNEXIS, Inc.
 SCYNEXIS, Inc. Pharmaceuticals: MajorHealth Technology Develops novel oral and intravenous triterpenoid antifungal for the treatment of several serious fungal infections | Health Technology |
Lafayette College
 Lafayette College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Health Technology |
AstraZeneca Pharmaceuticals LP
 AstraZeneca Pharmaceuticals LP Pharmaceuticals: MajorHealth Technology Manufactures biopharmaceuticals | Health Technology |
Medivation LLC (California)
 Medivation LLC (California) Pharmaceuticals: MajorHealth Technology Engages in the development of novel small molecule drugs to treat serious diseases | Health Technology |
Girls On The Run International
Girls On The Run International Miscellaneous Commercial ServicesCommercial Services Operates as an association that promotes girl empowerment by teaching life skills through lessons and running | Commercial Services |
CytomX Therapeutics, Inc.
 CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Sio Gene Therapies, Inc.
 Sio Gene Therapies, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops gene therapies to treat neurodegenerative diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
